L-threo Lysosphingomyelin (d18:1) (Synonyms: L-threo Lyso SM(18:1), L-threo Lysosphingomyelin (18:1), L-threo Sphingosine-1-Phosphocholine (d18:1), L-threo-Sphingosylphosphorylcholine) |
Catalog No.GC44086 |
L-thréo Lysosphingomyéline (d18:1) (L-thréo-Sphingosylphosphorylcholine) est un sphingolipide bioactif endogène. La L-thréo Lysosphingomyéline (d18:1) est un puissant agoniste des récepteurs S1P avec des CE50 de 19,3, 131,8 et 313,3 nM pour hS1P1, hS1P3 et hS1P2, respectivement.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 105615-55-2
Sample solution is provided at 25 µL, 10mM.
L-threo Lysosphingomyelin is an endogenous bioactive sphingolipid and isomer of lysosphingomyelin . It is an agonist of sphingosine-1-phosphate (S1P) receptors 1-3 (EC50s = 19.3, 313.3, and 131.8 nM for human S1P1-3, respectively).
Average Rating: 5
(Based on Reviews and 13 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *